Strata Critical Medical Inc. (Class A) (SRTA) exhibits 20.9% gross margins and -7.1% return on invested capital within Health Care (Medical/Nursing Services), balanced against a 10.2x enterprise multiple and 4.8% implied options volatility.
Sustained 20.9% gross profitability converts into -11.3% operating margin and -7.1% ROIC, outpacing sector cost of capital.
ROIC: -7.1% // GM: 20.9%YoY revenue trajectory of +34.3% paired with -13.92% free cash flow yield supports self-funded R&D and capital return.
REV YOY: +34.3% // FCF YLD: -13.92%Altman Z-Score of 5.58 and Piotroski F-Score of 4/9 indicate low near-term refinancing stress.
ALTMAN Z: 5.58 // F-SCORE: 4/9Trading at 10.2x trailing P/E (8.6x Fwd P/E) leaves valuation vulnerable if real 10Y TIPS yields spike.
P/E: 10.2x // EV/EBITDA: —Options market prices a ±5.2% implied move with a 0.85 put/call ratio around $4.28 max pain.
IMPL MOVE: ±5.2% // P/C: 0.85Elevated industry capital intensity and customer concentration in Medical/Nursing Services require continuous execution to defend 21.0% net margins.
NET MARGIN: 21.0% // D/E: 0.45x| FILER | SIDE | $ VALUE |
|---|---|---|
| INSPECT FULL OWNERSHIP LEDGER IN OWN <GO> | ||
| STRIKE / EXP | TYPE | PREMIUM |
|---|---|---|
| INSPECT GEX & CHAIN IN OPT <GO> | ||
Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for SRTA & activate live FRED threshold breach alerts.